Monday
09:00 - 15:00
Servet Hall

Cardio-Renal-Metabolic Revolution: Are You Ready?

Full Day Session

John Buse (USA), Francesco Giorgino (Italy)
Cardiovascular-renal-metabolic management of patients with T2D: The journey so far
Eduard Montanya (Spain), Jiten Vora (UK)
Welcome and introductions
Subodh Verma (Canada), Mark Petrie (UK), Roopa Mehta (Mexico), David Cherney (Canada), Naresh Kanimilli (UK)
Cardio-renal-metabolic general practitioner consult: Preventing complications in a recently diagnosed patient with T2D
Subodh Verma (Canada), Mark Petrie (UK), Francesco Giorgino (Italy), Roopa Mehta (Mexico), David Cherney (Canada), Naresh Kanumilli (UK)
Five years on: Maintaining glycemic control and maximizing cardio-renal risk reduction
Mark Petrie (UK), Francesco Giorgino (Italy), Roopa Mehta (Mexico), David Cherney (Canada), Naresh Kanumilli (UK)
Moving along the risk continuum: Managing multiple vascular complications
Subodh Verma (Canada), Mark Petrie (UK), Filip Knop (Denmark), Roopa Mehta (Mexico), Hiddo L Heerspink (The Netherlands)
Reducing the risk of recurrent CV events, post ACS
Subodh Verma (Canada), Mark Petrie (UK), Filip Knop (Denmark), Roopa Mehta (Mexico), Hiddo L Heerspink (The Netherlands)
Preventing further cardio-renal decline
John Buse (USA), Subodh Verma (Canada), Mark Petrie (UK), Hiddo L Heerspink (The Netherlands)
Summary and overview: Optimizing therapy for risk mitigation across the cardio-renal-metabolic continuum
John Buse (USA), Francesco Giorgino (Italy)
Cardio-renal-metabolic risk minimization in T2D: The revolution
Eduard Montanya (Spain), Jiten Vora (UK)
Summary and close
Symposium by: